Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

532 ARTÍCULOS , VIENDO DEL 421 AL 435

Biosensors for detection of Tau protein as an Alzheimer's disease marker

Ameri M, Shabaninejad Z, Movahedpour A, Sahebkar A, Mohammadi S, Hosseindoost S, Ebrahimi MS, Savardashtaki A, Karimipour M, Mirzaei H.

Int J Biol Macromol. 2020 Nov 1;162:1100-1108. doi: 10.1016/j.ijbiomac.2020.06.239. Epub 2020 Jun 27.

Leveraging preclinical models for the development of Alzheimer disease therapeutics

Scearce-Levie K, Sanchez PE, Lewcock JW.

Nat Rev Drug Discov. 2020 Jul;19(7):447-462. doi: 10.1038/s41573-020-0065-9. Epub 2020 Apr 8.

Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences

Lombardi G, Pupi A, Bessi V, Polito C, Padiglioni S, Ferrari C, Lucidi G, Berti V, De Cristofaro MT, Piaceri I, Bagnoli S, Nacmias B, Sorbi S.

J Alzheimers Dis. 2020;77(1):203-217. doi: 10.3233/JAD-200119.

Correlation of Alzheimer Disease Neuropathologic Staging with Amyloid and Tau Scintigraphic Imaging Biomarkers

Koychev I, Hofer M, Friedman N.

J Nucl Med. 2020 Oct;61(10):1413-1418. doi: 10.2967/jnumed.119.230458. Epub 2020 Aug 6.

Associations of Green Tea Consumption and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study

Ma YH, Wu JH, Xu W, Shen XN, Wang HF, Hou XH, Cao XP, Bi YL, Dong Q, Feng L, Tan L, Yu JT.

J Alzheimers Dis. 2020;77(1):411-421. doi: 10.3233/JAD-200410.

Revisiting the Amyloid Cascade Hypothesis: From Anti-Aβ Therapeutics to Auspicious New Ways for Alzheimer's Disease

Uddin MS, Kabir MT, Rahman MS, Behl T, Jeandet P, Ashraf GM, Najda A, Bin-Jumah MN, El-Seedi HR, Abdel-Daim MM.

Int J Mol Sci. 2020 Aug 14;21(16):5858. doi: 10.3390/ijms21165858.

Surface plasmon resonance biosensors for detection of Alzheimer's biomarkers; an effective step in early and accurate diagnosis

Rezabakhsh A, Rahbarghazi R, Fathi F.

Biosens Bioelectron. 2020 Nov 1;167:112511. doi: 10.1016/j.bios.2020.112511. Epub 2020 Aug 17.

PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients

Wang HY, Pei Z, Lee KC, Lopez-Brignoni E, Nikolov B, Crowley CA, Marsman MR, Barbier R, Friedmann N, Burns LH.

J Prev Alzheimers Dis. 2020;7(4):256-264. doi: 10.14283/jpad.2020.6.

A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group

O'Gorman C, Khoury R, Anderson A, Carter M, DiCesare F, Dubé S, Ereshefsky L, Grossberg G, Hefting N, Khan S, Lind S, Moebius H, Shiovitz T, Rosenberg P.

J Prev Alzheimers Dis. 2020;7(4):274-282. doi: 10.14283/jpad.2020.37.

Cerebrovascular pathology in Alzheimer's disease: Hopes and gaps

Badji A, Westman E.

Psychiatry Res Neuroimaging. 2020 Dec 30;306:111184. doi: 10.1016/j.pscychresns.2020.111184. Epub 2020 Sep 7.

Challenges in demonstrating the value of disease-modifying therapies for Alzheimer's disease

Gustavsson A, Pemberton-Ross P, Gomez Montero M, Hashim M, Thompson R.

Expert Rev Pharmacoecon Outcomes Res. 2020 Dec;20(6):563-570. doi: 10.1080/14737167.2020.1822738. Epub 2020 Sep 20.

Neprilysin expression and functions in development, ageing and disease

Nalivaeva NN, Zhuravin IA, Turner AJ.

Mech Ageing Dev. 2020 Dec;192:111363. doi: 10.1016/j.mad.2020.111363. Epub 2020 Sep 26.

Association of Cigarette Smoking With Cerebrospinal Fluid Biomarkers of Neurodegeneration, Neuroinflammation, and Oxidation

Liu Y, Li H, Wang J, Xue Q, Yang X, Kang Y, Li M, Xu J, Li G, Li C, Chang HC, Su KP, Wang F.

JAMA Netw Open. 2020 Oct 1;3(10):e2018777. doi: 10.1001/jamanetworkopen.2020.18777.

The Dual Role of Glutamatergic Neurotransmission in Alzheimer's Disease: From Pathophysiology to Pharmacotherapy

Bukke VN, Archana M, Villani R, Romano AD, Wawrzyniak A, Balawender K, Orkisz S, Beggiato S, Serviddio G, Cassano T.

Int J Mol Sci. 2020 Oct 9;21(20):7452. doi: 10.3390/ijms21207452.

β-Secretase1 biological markers for Alzheimer's disease: state-of-art of validation and qualification

Hampel H, Lista S, Vanmechelen E, Zetterberg H, Giorgi FS, Galgani A, Blennow K, Caraci F, Das B, Yan R, Vergallo A; Alzheimer’s Precision Medicine Initiative (APMI).

Alzheimers Res Ther. 2020 Oct 16;12(1):130. doi: 10.1186/s13195-020-00686-3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias